Limits RegistryPUBLIC RECORD
Limits RegistryOn 19 March 1987, the US FDA approved zidovudine (AZT, Retrovir, Burroughs Wellcome), a nucleoside reverse-transcriptase inhibitor, for the treatment of HIV/AIDS after one of the fastest reviews in FDA history. AZT was first synthesised in 1964 as a potential cancer drug; its anti-HIV activity was shown at the US National Cancer Institute in 1985.
The question, scope, and sources behind this Registry record.
On 19 March 1987, the US FDA approved zidovudine (AZT, Retrovir, Burroughs Wellcome), a nucleoside reverse-transcriptase inhibitor, for the treatment of HIV/AIDS after one of the fastest reviews in FDA history. AZT was first synthesised in 1964 as a potential cancer drug; its anti-HIV activity was shown at the US National Cancer Institute in 1985.
The year in which a drug regulator first approved a medicine that directly inhibits HIV replication.
Change a parameter to stress-test whether a proposed result is still inside the published specification. This is an audit aid, not a proof checker.
This record has no editable parameters. Read the formal question and assumptions before challenging it.
Current frontiers derived from accepted Claims.
An observed or demonstrated result; no opposing bound is implied.
The frontier is not sacred
Most progress starts with a disagreement that survives contact with evidence. If you can push the known lower bound up or pull the upper bound down, show us the work.
≥ when you have shown that at least this value is achievable.≤ when you have shown that anything above this value is impossible.No vibes. State the value, define the scope, and link the paper, proof, code, or reproduction that lets another person check it. Editors review every challenge before the public record changes.
Challenge this recordAssertions tied to evidence, attribution, and review.
The frontier as it changed over time.
Only accepted Claims matching the current specification contribute to the displayed bounds. Strict inequalities remain open; contradictory Claims require editorial review.
1 accepted Claim, with 1 linked evidence records.
Permanent ID limitsregistry.com/limits/LR-FIRST-HIV-ANTIRETROVIRAL-APPROVED
No active verified bounties are linked to this Limit.
View verified bounty tracker ↗No accepted machine-checked reproductions are recorded for this Limit.
Limits Registry. LR-FIRST-HIV-ANTIRETROVIRAL-APPROVED. First antiretroviral drug approved for HIV. 2026.